Vimarsana
Biggest News Aggregation in the World

Page 24 - Aadi Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aadi Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aadi Bioscience Today - Breaking & Trending Today

Aadi Bioscience (NASDAQ:AADI) Issues Quarterly Earnings Results - Vimarsana News

Aadi Bioscience (NASDAQ:AADI) Issues Quarterly Earnings Results

Aadi Bioscience (NASDAQ:AADI – Get Rating) announced its earnings results on Thursday. The company reported ($0.66) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.68) by $0.02, MarketWatch Earnings reports. During the same quarter last year, the company earned ($0.90) EPS. Shares of NASDAQ:AADI opened at $14.02 on Friday. Aadi Bioscience […]

UPDATE -- Aadi Bioscience Reports First Quarter 2022 - Vimarsana News

UPDATE -- Aadi Bioscience Reports First Quarter 2022

FYARRO net product sales of $2.3 million in partial first quarterDosing of patients initiated in PRECISION 1, a Phase 2 tumor-agnostic...

$510,000.00 in Sales Expected for Aadi Bioscience, Inc. (NASDAQ:AADI) This Quarter - Vimarsana News

$510,000.00 in Sales Expected for Aadi Bioscience, Inc. (NASDAQ:AADI) This Quarter

Brokerages forecast that Aadi Bioscience, Inc. (NASDAQ:AADI – Get Rating) will announce sales of $510,000.00 for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Aadi Bioscience’s earnings. The highest sales estimate is $780,000.00 and the lowest is $250,000.00. The business is scheduled to announce its next quarterly earnings results before […]

Aadi Bioscience to Announce First Quarter 2022 Financial - Vimarsana News

Aadi Bioscience to Announce First Quarter 2022 Financial

Company to hold conference call on May 12th at 8:30 am EDT...

Aadi Bioscience, Inc. (NASDAQ:AADI) Given Average Recommendation of "Buy" by Analysts - Vimarsana News

Aadi Bioscience, Inc. (NASDAQ:AADI) Given Average Recommendation of "Buy" by Analysts

Shares of Aadi Bioscience, Inc. (NASDAQ:AADI – Get Rating) have received a consensus rating of “Buy” from the six ratings firms that are covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12 month price objective […]